- Synonyms2-methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one;3,4,10,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-1(2H)-one;Mirtazapine Impurity C; USP Mirtazapine Related Compound C; Mirtazapine EP Impurity C; Mirtazapine USP Related Compound C
- Description
2-methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one;3,4,10,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-1(2H)-one;Mirtazapine Impurity C; USP Mirtazapine Related Compound C; Mirtazapine EP Impurity C; Mirtazapine USP Related Compound C
Mirtazapine EP Impurity C is a fully characterized chemical compound used as a reference standard of API Mirtazapine. The standard offered is compliant with regulatory guidelines. Mirtazapine EP Impurity C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 191546-96-0
Related products
Mirtazapine-13C-d3 HCl

M.F.
M.W. 269.37 36.46
CAT# AR-M02040
CAS# 85650-52-8 (non-labelled and free base)